Divya Vasudevan, Ph.D.
About Divya Vasudevan, Ph.D.
Divya Vasudevan, Ph.D., is the Director, Cell Therapy CI Lead at Bristol Myers Squibb, with extensive experience in oncology strategy and competitive analysis from her tenure at Agenus.
Title and Current Role
Divya Vasudevan, Ph.D., is the Director and Cell Therapy CI Lead at Bristol Myers Squibb in New Jersey, United States. In this role, she leads a team focused on competitive intelligence within the cell therapy space.
Previous Roles at Agenus
Divya Vasudevan spent several years at Agenus in various roles from Associate Director to Senior Director of Oncology Strategy and Investor Relations. Her roles involved oncology strategy, competitive analysis, and providing strategic insights as Chief of Staff to the CEO. Her tenure at Agenus spanned multiple locations, including Lexington, MA, and New York, NY.
Educational Background
Divya Vasudevan holds a Doctor of Philosophy (Ph.D.) in Medicinal Chemistry from the University of Illinois Chicago. She also earned a Bachelor of Technology (B.Tech.) in Pharmaceutical Chemistry and Technology from the Institute of Chemical Technology, Mumbai, India.
Experience in Research and Teaching
At the University of Illinois at Chicago, Divya Vasudevan worked as a Research Assistant in the Lab of Dr. Douglas Thomas, focusing on medicinal chemistry and pharmacognosy. Additionally, she gained teaching experience as a Teaching Assistant in the College of Pharmacy.
Industry and Leadership Roles
Throughout her career, Divya Vasudevan has held multiple leadership and consultant roles. She worked as a Lead Commercialization and Strategy Consultant at EnterpriseWorks Chicago and chaired the Oxygen Radicals session at the Gordon Research Seminars in 2016. She has also interned at Regeneron Pharmaceuticals, Pfizer, and Unique Biotech, acquiring early industry experience.